Federal bill introduced to change hemp definition to 1% THC
Todd Runestad | Apr 01, 2021 The Hemp Economic Mobilization Plan (HEMP) Act of 2021 was recently introduced by Sen. Rand Paul (R-Ky.). Its goal is to address problems that have plagued hemp CBD for years and would make life easier for farmers and processors hemmed in by drug warrioring regulators. “For years, I’ve led the fight in Washington to […]
Cannabis banking bill passes U.S. House, seeks to ease hemp trade
Todd Runestad | Apr 20, 2021 As if by design, on the eve of 4/20, the U.S. House of Representatives overwhelmingly passed the SAFE Banking Act by a vote of 321-101, paving the way for cannabis businesses to access the financial system. “The banking drama I believe has impacted hemp just as much as, if not more than, […]
Examining The U.S. Department Of Agriculture’s Final Rule For Growing Hemp
Robert Hoban Mar 14, 2021, The final rule will have a major impact on the growth and viability of the industrial hemp sector … [+] GETTY States are allowed to enact their own programs based on the 2018 Farm Bill Provisions surrounding industrial hemp, but they must be approved by USDA. There were a number of states […]
Experienced Growers Suggest Planning Ahead and Starting Slow to Expand Your Industrial Hemp Operations
May 18, 2021 Allison Troutner Rick Lohre/Adobe Stock Hemp growing is a passionate endeavor for many farmers. With thousands of potential uses including sustainable alternatives to plastic, fossil fuels, and building materials, growers are eager to expand their hemp acreage to stay ahead of the curve in a burgeoning market. Unlike Canada and China, however, […]
Delta-8 THC in the DEA’s Orange Book: What It Means
By Patrick Williams May 14, 2021 Delta-8 tetrahydrocannabinol (THC) has appeared in the U.S. Drug Enforcement Administration’s (DEA) “Orange Book” and is in an online version dated May 10. This list of controlled substances lists delta-8 THC as “[another] name” for tetrahydrocannabinols. Tetrahydrocannabinols are listed in the Title 21 Code of Federal Regulations, Part 1308. However, the federal […]
Hemp CBD extractors can comment on onerous DEA rule
Todd Runestad | Mar 31, 2021 When in the course of extracting CBD oil from hemp biomass, an almost inevitable occurrence is a brief moment where the intermediary hemp material (IHM) concentrates the cannabinoid content to more than 0.3% THC. This is routinely remediated out to waste hemp material (HWM) so that the finished product has […]
CBD Oil And Parkinsons
“…Patients may have significant improvement of their symptoms after beginning Parkinson’s disease treatment. Over time, however, the benefits of drugs frequently diminish or become less consistent, although symptoms can often be fairly well-controlled. Traditional methods for coping for with Parkinson’s is available at the Parkinson’s Foundation website. I can save you the visit as the support comes […]
The DEA and CBD – New Drug Code for CBD
By Ted Mortenson “…According to an announcement as far back as n September 2018, the DEA announced that drugs including CBD products containing a range from zero to 0.1% THC content are considered “Schedule 5” controlled substances and dangerous drugs forthwith. This announcement is the first time the agency has lowered any type of Cannabis-derived cannabinoid […]
Feds To Send Marijuana And Hemp Samples To Labs As Part Of Large-Scale Testing Accuracy Study
Published 6 months ago on January 15, 2021 By Kyle Jaeger A federal science agency is inviting labs to participate in a large-scale study to assess their ability to accurately analyze marijuana and hemp samples for their cannabinoid profile and possible contaminants. “…If you’re going to confiscate a farmer’s crop, or subject a person to prosecution, you want […]
FDA WARNS CBD COMPANIES OVER OPIOID CLAIMS
A.J. HERRINGTON MAY 14, 2020 The U.S. Food and Drug Administration has issued warning letters to two companies for making unsubstantiated claims that their CBD products can be used as an alternative to opioids or as a treatment for opioid addiction. The letters were sent to BIOTA Biosciences, LLC in the state of Washington and […]